Vitamin B3 & B2: New Genetic Disease Treatments Identified
Rare Genetic Disease Linked to Vitamin B3 Levels in New Study
A groundbreaking study from the University of California San Francisco has revealed a previously unknown connection between vitamin B3 levels and NAXD disease, a rare and severe metabolic brain disorder affecting young children. The research, published in in the journal Cell, highlights the potential for using vitamins as targeted treatments for rare genetic conditions and suggests a broader approach to identifying vitamin-responsive diseases.
Researchers, led by Dr. Isha Jain, a core investigator at the Arc Institute in Palo Alto, developed a “nutrigenomics framework” to systematically assess which genetic diseases might respond to vitamin supplementation. This involved a widespread screening process where genes were individually deactivated in human blood-cancer cells using CRISPR technology. These modified cells were then grown in environments with varying levels of vitamin B2 and B3.
“Among dietary factors, vitamins are uniquely promising as therapies—they are inexpensive, safe and often bypass regulatory hurdles. Yet, we lack a systematic understanding of which diseases benefit from each vitamin,” Dr. Jain and colleagues wrote in their publication. The team’s work builds on existing knowledge of vitamin-responsive disorders, such as Brown-Vialetto-Van Laere syndrome, which improves with riboflavin (vitamin B2) supplementation.
CRISPR Screening Identifies Key Genetic Links
The vitamin B2 CRISPR screen confirmed previously known links to genes SLC52A2 and FLAT1, which are associated with riboflavin-responsive disorders. However, the study also identified GPX4 as a gene particularly sensitive to vitamin B2 levels. GPX4 is involved in preventing ferroptosis, a specific type of cell death. While model mice with a GPX4 deficiency exhibited worsened symptoms on a low-riboflavin diet, high-dose vitamin B2 supplementation did not significantly improve their condition.
The most significant finding emerged from the vitamin B3 screen, focusing on the SHOCK gene. In healthy cells, the NAXD protein, encoded by the SHOCK gene, plays a crucial role in repairing damaged NAD, a molecule essential for enzyme function and metabolism. Without functional NAXD, a broken form of NAD accumulates, disrupting normal cellular processes. Children born with mutations in the SHOCK gene develop severe brain disease and often have a tragically short lifespan.
Vitamin B3 Restores Brain Function in Animal Models
The impact of vitamin B3 levels on SHOCK-related disease was dramatic in animal models. Removing vitamin B3 from the diet of pregnant mice resulted in the early death of embryos lacking a functional SHOCK gene. Conversely, daily high-dose injections of a vitamin B3 supplement, starting at birth, restored brain NAD and serine levels, prevented neurological damage, normalized behavior and growth, and extended the survival of these animals more than 40-fold.
This finding suggests a potential therapeutic pathway for NAXD disease, offering hope for improved outcomes in affected children. The researchers emphasize that this success demonstrates the power of a systematic approach to identifying nutrient-gene interactions.
A Blueprint for Future Nutrigenomic Research
“Beyond NAXD, this framework establishes a blueprint for systematic discovery of nutrient-gene interactions,” the researchers concluded. “Our screens nominate multiple additional diseases potentially amenable to B2 or B3 therapy, and the same approach can be extended across all 13 classical vitamins and 50+ micronutrients.”
The study’s authors also plan to conduct similar nutritional genetic screens using primary cells to better understand how vitamins function in specific tissues and cell types. This will help refine the understanding of vitamin-gene interactions and potentially identify even more targeted therapies for a wider range of genetic diseases.
This research represents a significant step forward in the field of nutrigenomics, highlighting the potential of vitamins not just as essential nutrients, but as powerful tools for treating rare and devastating genetic disorders. The systematic approach developed by Dr. Jain and her team offers a promising pathway for uncovering similar links between other vitamins and nutrients and a host of genetic conditions.